Suggested Topics within your search.
Showing 181 - 200 results of 371 for search '"Neurological disorder"', query time: 0.05s Refine Results
  1. 181

    A Novel CACNA1A Nonsense Variant [c.4054C>T (p.Arg1352⁎)] Causing Episodic Ataxia Type 2 by Sean Lance, Stuart Mossman, Gemma Poke

    Published 2018-01-01
    “…Episodic ataxia is a heterogenous group of uncommon neurological disorders characterised by recurrent episodes of vertigo, dysarthria, and ataxia for which a variety of different genetic variations have been implicated. …”
    Get full text
    Article
  2. 182

    “Dancing Eye Syndrome” Secondary to Opsoclonus-Myoclonus Syndrome in Small-Cell Lung Cancer by S. Laroumagne, Xavier Elharrar, B. Coiffard, J. Plojoux, H. Dutau, D. Breen, P. Astoul

    Published 2014-01-01
    “…Among paraneoplastic neurologic disorders (PND), opsoclonus-myoclonus syndrome, so-called “dancing eye syndrome,” is a rare disorder combining multivectorial eye movements, involuntary multifocal myoclonus, and cerebellar ataxia. …”
    Get full text
    Article
  3. 183

    GABAergic Neuron Specification in the Spinal Cord, the Cerebellum, and the Cochlear Nucleus by Kei Hori, Mikio Hoshino

    Published 2012-01-01
    “…The elaborate balance of the activities of the two types is very important to elicit higher brain function, because its imbalance may cause neurological disorders, such as epilepsy and hyperalgesia. …”
    Get full text
    Article
  4. 184

    The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke by Nada H. Aljarba, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Mustafa M. Shokr, Marios Papadakis, Athanasios Alexiou, Mubarak Alruwaili, Mohammed Alrouji, Mohammed S. Alshammari, Gaber El-Saber Batiha

    Published 2025-03-01
    “…AGEs-induced cellular aging is implicated in the development and progression of different neurological disorders such as dementia, neuropsychiatric disorders, and cerebrovascular diseases. …”
    Get full text
    Article
  5. 185

    Protocol for correlating the gut microbiome and metabolomics in patients with intracranial aneurysms by Hongyu Xu, Zetian Jia, Junhui Liu, Runming Liu, Wei Wei, Xiang Li

    Published 2025-03-01
    “…Summary: Gut-microbiome-combined metabolomics studies in cerebrovascular disease highlight the microbiota-gut-brain axis in neurological disorders. Here, we present a protocol for correlating the gut microbiome and metabolomics in patients with intracranial aneurysms. …”
    Get full text
    Article
  6. 186

    Vulvar Malignancy in Neurofibromatosis Syndrome by Angela Musella, Innocenza Palaia, Lavinia Domenici, Assunta Casorelli, Angela Martoccia, Pierluigi Benedetti Panici

    Published 2013-01-01
    “…Type 1 neurofibromatosis (NF1) is a dominantly inherited neurologic disorder that affects primarily the skin, bones, and peripheral nervous system. …”
    Get full text
    Article
  7. 187

    Involuntary Vocalisations and a Complex Hyperkinetic Movement Disorder Following Left Side Thalamic Haemorrhage by T. Dietl, D. P. Auer, S. Modell, C. Lechner, C. Trenkwalder

    Published 2003-01-01
    “…A variety of involuntary speech phenomena as for example palilalia have been described as consequences of neurological disorders. Palilalia is the involuntary repetition of syllabels, words and phrases in ongoing speech. …”
    Get full text
    Article
  8. 188
  9. 189

    Neuromodulatory Effects of Transcranial Direct Current Stimulation on Motor Excitability in Rats by Hui-Hua Liu, Xiao-Kuo He, Hsin-Yung Chen, Chih-Wei Peng, Alexander Rotenberg, Chi-Hung Juan, Yu-Cheng Pei, Hao-Li Liu, Yung-Hsiao Chiang, Jia-Yi Wang, Xiao-Jun Feng, Ying-Zu Huang, Tsung-Hsun Hsieh

    Published 2019-01-01
    “…This newly developed tDCS animal model could be useful to further explore mechanical insights and may serve as a translational platform bridging human and animal studies, establishing new therapeutic strategies for neurological disorders.…”
    Get full text
    Article
  10. 190
  11. 191
  12. 192

    Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia by Justine Chan, Paarth Shah, Guillermo Moguel-Cobos

    Published 2019-01-01
    “…The use of nilotinib in neurologic disorders is relatively new, and little information about this use has been published. …”
    Get full text
    Article
  13. 193

    A comparison of Bartonella henselae infection in immunocompetent and immunocompromised mice. by Rebekah L Bullard, Mercedes Cheslock, Shiva Kumar Goud Gadila, Ricardo G Maggi, Edward B Breitschwerdt, Ahmad A Saied, Monica E Embers

    Published 2024-01-01
    “…The breadth of disease manifestations associated with Bartonella is currently expanding and includes regional lymphadenopathy, rheumatic, ocular, and neurological disorders. The dearth of knowledge regarding diagnosis, treatment and pathogenesis of this disease can be partially attributed to the lack of a reliable small animal model for the disease. …”
    Get full text
    Article
  14. 194

    Neuroprotective Activity of (-)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity by Jin-Biao Liu, Li Zhou, Yi-Zhong Wang, Xu Wang, Yu Zhou, Wen-Zhe Ho, Jie-Liang Li

    Published 2016-01-01
    “…Thus EGCG represents a potent and useful neuroprotective agent for inflammation-mediated neurological disorders.…”
    Get full text
    Article
  15. 195

    Epstein-Barr Virus Encephalitis in an Immunocompetent Child: A Case Report and Management of Epstein-Barr Virus Encephalitis by Gulsen Akkoc, Eda Kepenekli Kadayifci, Ayse Karaaslan, Serkan Atici, Nurhayat Yakut, Sevliya Ocal Demir, Ahmet Soysal, Mustafa Bakir

    Published 2016-01-01
    “…Epstein-Barr virus-related neurological disorders include meningitis, encephalitis, and cranial or peripheral neuritis, which are mostly seen in immunocompromised patients. …”
    Get full text
    Article
  16. 196

    Brain connectivity by single-photon emission computed tomography and graph theory: a mini-review by Carlos A. Sanchez-Catasus, Karla Batista-García-Ramó, Lester Melie-Garcia

    Published 2023-09-01
    “… Current neuroimaging technologies play an important role in neurological disorders. Among these technologies, nuclear medicine neuroimaging such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) play a key role. …”
    Get full text
    Article
  17. 197

    MRI Findings in Neuroferritinopathy by Emiko Ohta, Yoshihisa Takiyama

    Published 2012-01-01
    “…Based on observations of an excessive iron content in patients with chronic neurologic disorders, such as Parkinson disease and Alzheimer disease, the presence of excess iron is therefore recognized as a major risk factor for neurodegenerative diseases. …”
    Get full text
    Article
  18. 198

    Design of a Savitzky-Golay Filter-Based vEMG-FES System by Ruikai Cao, Yixuan Sheng, Anqin Dong, Honghai Liu

    Published 2025-01-01
    “…It is evident that voluntary effort plays a crucial role in electrical stimulation rehabilitation, facilitating neuroplasticity enhancement in patients with neurological disorders. In this paper, we present a multichannel system designed for simultaneous functional electrical stimulation (FES) and volitional EMG (vEMG) acquisition using shared electrodes. …”
    Get full text
    Article
  19. 199

    Artificial intelligence-based video monitoring of movement disorders in the elderly: a review on current and future landscapes by Kye Won Park, Maryam S Mirian, Martin J McKeown

    Published 2024-03-01
    “…Due to global ageing, the burden of chronic movement and neurological disorders (Parkinson’s disease and essential tremor) is rapidly increasing. …”
    Get full text
    Article
  20. 200

    Role of MicroRNA in Governing Synaptic Plasticity by Yuqin Ye, Hongyu Xu, Xinhong Su, Xiaosheng He

    Published 2016-01-01
    “…A review is made here on the function of miRNAs in governing synaptic plasticity, emphasizing the emerging regulatory role of individual miRNAs in synaptic morphological and functional plasticity, as well as their implications in neurological disorders. Understanding of the way in which miRNAs contribute to synaptic plasticity provides rational clues in establishing the novel therapeutic strategy for plasticity-related diseases.…”
    Get full text
    Article